Want to join the conversation?
Greg Melich of Evercore ISI asks about gross margin. $WSM said GM was down, predominantly associated with supply chain challenges. The company is seeing a comeback and it is gaining momentum. $WSM is seeing opportunities to get to better levels and moving forward, it believes to see improvements in GM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.